| CAS: | 89987-06-4 | |
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||
| T4580 | Sigma-Aldrich | Tiludronate disodium salt hydrate | ≥98% (HPLC) | 992.72元/10 MG; 3157.38元/50 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||
产品说明 包装 10, 50 mg in glass bottle 生化/生理作用 Tiludronate is a bisphosphonate bone resorption inhibitor. Tiludronate inhibits protein-tyrosine-phosphatase, leading to detachment of osteoclasts from the bone surface. It also inhibits the osteoclastic proton pump and is used to treat Paget′s disease. 特点和优势 This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. 制备说明 Tiludronate disodium salt hydrate is soluble in DMSO at a concentration that is greater than or equal to 10 mg/ml. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||